Isolation and structure elucidation of major alkaline degradant of ezetimibe.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2011-04-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jpba.2010.12.033PMID 21288678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.

  2010cited by this paper
• Application of a stability-indicating TLC method for the quantitative determination of Levocetirizine in pharmaceutical dosage forms

  2010cited by this paper
• Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column.

  2009cited by this paper
• Development and Validation of HPLC, TLC and Derivative Spectrophotometric Methods for the Analysis of Ezetimibe in the Presence of Alkaline Induced Degradation Products

  2009cited by this paper
• Validation of a Stability-Indicating LC Method for Assay of Ezetimibe in Tablets and for Determination of Content Uniformity

  2008cited by this paper
• Development and Validation of a Stability-indicating Micellar Electrokinetic Chromatography Method for the Determination of Ezetimibe in Pharmaceutical Formulations

  2008cited by this paper
• Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products.

  2007cited by this paper
• Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug products.

  2007cited by this paper
• Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay.

  2006cited by this paper
• Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms.

  2005cited by this paper
• SELECTIVE CHOLESTEROL ABSORPTION INHIBITION: A NOVEL STRATEGY IN LIPID‐LOWERING MANAGEMENT

  2002cited by this paper
• Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

  2001cited by this paper
• Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

  2000cited by this paper
• Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption

  year unknowncited by this paper

• Ezetimibe: A Review of Analytical Methods for the Drug Substance, Pharmaceutical Formulations and Biological Matrices

  2020cites this paper
• Ezetimibe

  2020cites this paper
• Structural Correction and Process Improvement for Control of a Critical Process Impurity of Ezetimibe

  2019cites this paper
• Development of an LC-MS Method for 4-Fluoroaniline Determination in Ezetimibe.

  2018cites this paper
• Densitometric Determination of Ezetimibe in the Presence of its Alkaline Degradation Product

  2018cites this paper
• “Ghost peaks” of ezetimibe: Solution degradation products of ezetimibe in acetonitrile induced by alkaline impurities from glass HPLC vials

  2017cites this paper
• Synchronized Determination of Four Antidiabetic and Antihyperlipidemic Drugs by a Validated LC Method

  2016influential citation
• Chiral Separation and Thermodynamic Investigation of Ezetimibe Optical Isomers on a Chiralpak IC Column.

  2016cites this paper
• Application of Quality by Design for the Optimization of an HPLC Method to Determine Ezetimibe in a Supersaturable Self-Nanoemulsifying Formulation

  2015cites this paper
• Investigation of reduction process and related impurities in ezetimibe.

  2015cites this paper
• Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate.

  2015cites this paper
• Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.

  2014cites this paper
• harmaceutical impurities and degradation products : Uses and pplications of NMR techniques

  2014cites this paper
• Kinetics and mechanism of the base-catalyzed rearrangement and hydrolysis of ezetimibe.

  2014influential citation
• Identification, isolation and characterization of process related impurities in ezetimibe.

  2014cites this paper
• RP-HPLC-UV Determination of ezetimibe in serum: Method development, validation and application to patients chronically receiving the drug

  2013cites this paper
• Structure of the major degradant of ezetimibe.

  2012cites this paper
• A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.

  2012cites this paper
• TLC- Densitometric Method for Determination of some Cholesterol Lowering Drugs in Different Combinations

  2012cites this paper
• Two spectrophotometric methods for simultaneous determination of some antihyperlipidemic drugs

  2012cites this paper
• What is the degradation product of ezetimibe?

  2011cites this paper
• Impurity Profiling: A Case Study of Ezetimibe

  2011cites this paper